LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Clinical trials for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat blood cancers in major trial
Disease control Recruiting nowThis study is testing whether a new drug combination works better than the current standard treatment for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma that has returned or stopped responding to prior therapy. Researchers will compare the safety and effec…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Tailored treatment aims to tame blood cancer with fewer side effects
Disease control Recruiting nowThis study is testing whether adjusting the dose of the drug ibrutinib—either alone or combined with venetoclax—can effectively control chronic lymphocytic leukemia while reducing side effects. It will enroll 320 adults who have not yet received treatment for their CLL. The goal …
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New CAR-T cell therapy trial offers hope for patients with Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is testing an experimental cell therapy called JCAR017 for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or hasn't responded to other treatments. The therapy involves modifying a patient's own immune cells to figh…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE1, PHASE2 • Sponsor: Juno Therapeutics, a Subsidiary of Celgene • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists Re-Engineer Patients' own cells to hunt blood cancer
Disease control Recruiting nowThis study is testing a personalized cell therapy for adults with advanced B-cell leukemias that have not responded to standard drugs. Doctors take a patient's own immune cells, modify them in a lab to target a protein (CD19) found on their cancer cells, and then infuse them back…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Five-Year watch: tracking safety of blood cancer drug
Disease control Recruiting nowThis study aims to monitor the long-term safety of the drug pirtobrutinib in people with previously treated blood cancers like chronic lymphocytic leukemia and lymphoma. It is only open to a small group of 13 people who are already benefiting from the drug in a previous trial. Pa…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Prescribing a walk: can simple exercise boost life quality for blood cancer patients?
Symptom relief Recruiting nowThis study is testing if a personalized physical activity program can improve the day-to-day well-being of people with chronic lymphocytic leukemia (CLL) who are starting a medication called ibrutinib. It will involve 180 participants who will follow an exercise plan and track th…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Sponsor: Janssen Cilag S.A.S. • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
Scientists hunt family clues to blood cancers
Knowledge-focused Recruiting nowThis study aims to understand why certain blood and lymph cancers sometimes run in families. Researchers are enrolling families where at least two blood relatives have been diagnosed with these cancers. The goal is to learn how genetics and environmental factors might work togeth…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:20 UTC